Andrew A. Wolff

Andrew Wolff has extensive experience in clinical research and development, currently serving as an Independent Consultant since January 2020. Previously, Andrew held various leadership roles at Cytokinetics, Inc. from September 2004 to January 2020, including Chief Medical Officer and Senior Vice President. Andrew's career also includes a tenure at CV Therapeutics from 1994 to 2004 in the same executive capacity, and positions held at Syntex as Executive Director & Clinical Program Leader from 1988 to 1994. Andrew earned a Doctor of Medicine (M.D.) from Washington University in St. Louis and a Bachelor of Science (B.S.) in Biology and Chemistry from the University of Dayton.